Cartesian Therapeutics, Inc. (RNAC)
(Delayed Data from NSDQ)
$24.60 USD
-1.23 (-4.76%)
Updated May 21, 2024 04:00 PM ET
After-Market: $24.57 -0.03 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/15/24 |
---|---|
Current Quarter | -0.94 |
EPS Last Quarter | -1.97 |
Last EPS Surprise | -143.21% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.92 |
Next Year | -3.65 |
EPS (TTM) | -8.88 |
P/E (F1) | 15.15 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 5.84M | NA |
# of Estimates | NA | NA | 1 | NA |
High Estimate | NA | NA | 5.84M | NA |
Low Estimate | NA | NA | 5.84M | NA |
Year ago Sales | 5.25M | 6.55M | 26.00M | 5.84M |
Year over Year Growth Est. | NA | NA | -77.54% | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.94 | -0.80 | -6.92 | -3.65 |
# of Estimates | 2 | 2 | 1 | 2 |
Most Recent Consensus | -0.92 | -0.65 | -6.92 | -3.20 |
High Estimate | -0.92 | -0.65 | -6.92 | -3.20 |
Low Estimate | -0.95 | -0.95 | -6.92 | -4.10 |
Year ago EPS | -2.10 | -2.40 | -10.21 | -6.92 |
Year over Year Growth Est. | 55.24% | 66.67% | 32.22% | 47.25% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.94 | -0.80 | -6.92 | -3.65 |
7 Days Ago | -0.94 | -0.80 | -6.92 | -3.65 |
30 Days Ago | -0.30 | -0.30 | -1.50 | -2.10 |
60 Days Ago | -0.30 | -0.30 | -3.90 | -2.10 |
90 Days Ago | -1.20 | -0.60 | -5.41 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.94 | -0.80 | -6.92 | -3.65 |
Zacks Consensus Estimate | -0.94 | -0.80 | -6.92 | -3.65 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.97 | -2.40 | -2.40 | -2.10 | NA |
Estimate | -0.81 | -0.30 | -2.10 | -2.70 | NA |
Difference | -1.16 | -2.10 | -0.30 | 0.60 | -0.74 |
Surprise | -143.21% | -700.00% | -14.29% | 22.22% | -208.82% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more